ENDRA Life Sciences (NDRA) FCF Payout Ratio (2019 - 2021)

ENDRA Life Sciences (NDRA) has reported FCF Payout Ratio for 3 consecutive years, with 0.01 the latest figure, recorded in Q1 2021.

• In Q1 2021, FCF Payout Ratio fell 168.71% year-over-year to 0.01; the TTM figure through Dec 2021 stood at 0.0 (up 94.01% YoY), while the FY2021 annual figure was 0.01, up 70.34% from the prior year.
• FCF Payout Ratio advanced to 0.01 in Q1 2021 per NDRA's latest filing, from 0.16 in the prior quarter.
• Across five years, FCF Payout Ratio topped out at 0.01 in Q1 2020 and bottomed at 2.17 in Q4 2019.
• Historically, FCF Payout Ratio has averaged 0.47 across 3 years, with a median of 0.02 in 2020.
• Annual changes were most pronounced in 2020 — FCF Payout Ratio soared 92.5% — and 2021, when it sank 168.71%.
• ENDRA Life Sciences' FCF Payout Ratio stood at 2.17 in 2019, then jumped by 92.5% to 0.16 in 2020, then soared by 95.38% to 0.01 in 2021.
• Business Quant data shows NDRA's FCF Payout Ratio at 0.01 in Q1 2021, 0.16 in Q4 2020, and 0.02 in Q3 2020.